GeneReach Biotechnology Corp. (4171)
Market Closed
12 Aug, 05:30
TWSE 
JPX Primary TWSE NT$
17. 25
+0.25
+1.4706%
NT$
- Market Cap
- P/E Ratio
60% Div Yield
118,591 Volume
- Eps
NT$ 17
Previous Close Want to track 4171 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
GeneReach Biotechnology Corp. (4171) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.04B
Trailing P/E (ttm) -9.22
Forward P/E -
PEG ratio 0.76
Price/Sales (ttm) 4.2
Price/Book (mrq) 1.74
Enterprise Value/Revenue 4.47
Enterprise Value/EBITDA -30.31
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 191.94K
Average volume (90 days) 205.67K
Price summary
52-Week low 16.35
52-Week high 26.9
Beta -
50-Day moving average 17.43
200-Day moving average 18.73
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Mar 2026
Ex-Dividend Date 29 Dec 2025
Last split factor 1,250:1,000
Last split Date 28 Jul 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.45%
Operating margin -0.16%
Operational effectiveness
Return on assets -0.12%
Return on equity -0.18%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.89
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.77
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.8
Total debt (mrq) -
Total Debt/Equity (mrq) 0.37
Current ratio (mrq) 2.51%
Book value per share (mrq) 9.93
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
